Fencibutirol

This classification denotes a cholagogue or choleretic agent with the molecular formula C16H22O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H2V165956A, chemically known as cyclohexaneacetic acid, alpha-ethyl-1-hydroxy-4-phenyl-, (+-)- but generally known as fencibutirol, which bears US NIH Compound Identifier 71170. European Medicines Agency schedules Fencibutirol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07547MIG. The term FENCIBUTIROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). FENCIBUTIROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fencibutirol under HS 29181985 and SITC 51392. As of Q4 2014, FENCIBUTIROL remains the US FDA Preferred Term for this commodity. Fencibutirol bears US NLM identifiers UMLS ID C0060160 and NCI Concept Code C65641. SMILES: OC1(CCC(CC1)C1CCCCC1)C(CC)C(=O)O.